15-45402120-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000458245.5(GATM):​n.208C>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.31 in 395,098 control chromosomes in the GnomAD database, including 22,815 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 8863 hom., cov: 33)
Exomes 𝑓: 0.30 ( 13952 hom. )

Consequence

GATM
ENST00000458245.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.520

Publications

19 publications found
Variant links:
Genes affected
GATM (HGNC:4175): (glycine amidinotransferase) This gene encodes a mitochondrial enzyme that belongs to the amidinotransferase family. This enzyme is involved in creatine biosynthesis, whereby it catalyzes the transfer of a guanido group from L-arginine to glycine, resulting in guanidinoacetic acid, the immediate precursor of creatine. Mutations in this gene cause arginine:glycine amidinotransferase deficiency, an inborn error of creatine synthesis characterized by cognitive disability, language impairment, and behavioral disorders. [provided by RefSeq, Jul 2008]
AFG2B (HGNC:28762): (AFG2 AAA ATPase homolog B) Predicted to enable ATP binding activity. Located in cytoplasm and spindle. [provided by Alliance of Genome Resources, Apr 2022]
AFG2B Gene-Disease associations (from GenCC):
  • hearing loss, autosomal recessive 119
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hearing loss and spasticity
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.811 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AFG2BNM_024063.3 linkc.-310G>T upstream_gene_variant ENST00000305560.11 NP_076968.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GATMENST00000458245.5 linkn.208C>A non_coding_transcript_exon_variant Exon 1 of 5 1
GATMENST00000561148.5 linkc.-711C>A 5_prime_UTR_variant Exon 1 of 5 5 ENSP00000453860.1
AFG2BENST00000305560.11 linkc.-310G>T upstream_gene_variant 1 NM_024063.3 ENSP00000305494.6
AFG2BENST00000559860.2 linkn.-250G>T upstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.319
AC:
48499
AN:
152010
Hom.:
8842
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.296
Gnomad AMI
AF:
0.179
Gnomad AMR
AF:
0.473
Gnomad ASJ
AF:
0.347
Gnomad EAS
AF:
0.831
Gnomad SAS
AF:
0.353
Gnomad FIN
AF:
0.309
Gnomad MID
AF:
0.268
Gnomad NFE
AF:
0.258
Gnomad OTH
AF:
0.342
GnomAD4 exome
AF:
0.304
AC:
73827
AN:
242970
Hom.:
13952
Cov.:
2
AF XY:
0.303
AC XY:
38156
AN XY:
125910
show subpopulations
African (AFR)
AF:
0.286
AC:
1617
AN:
5658
American (AMR)
AF:
0.518
AC:
2661
AN:
5142
Ashkenazi Jewish (ASJ)
AF:
0.333
AC:
2729
AN:
8206
East Asian (EAS)
AF:
0.856
AC:
11673
AN:
13636
South Asian (SAS)
AF:
0.309
AC:
6689
AN:
21642
European-Finnish (FIN)
AF:
0.290
AC:
5365
AN:
18486
Middle Eastern (MID)
AF:
0.310
AC:
375
AN:
1210
European-Non Finnish (NFE)
AF:
0.247
AC:
37926
AN:
153422
Other (OTH)
AF:
0.308
AC:
4792
AN:
15568
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
2063
4125
6188
8250
10313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.319
AC:
48546
AN:
152128
Hom.:
8863
Cov.:
33
AF XY:
0.328
AC XY:
24387
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.296
AC:
12293
AN:
41492
American (AMR)
AF:
0.474
AC:
7252
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.347
AC:
1203
AN:
3470
East Asian (EAS)
AF:
0.831
AC:
4306
AN:
5180
South Asian (SAS)
AF:
0.351
AC:
1693
AN:
4824
European-Finnish (FIN)
AF:
0.309
AC:
3266
AN:
10570
Middle Eastern (MID)
AF:
0.277
AC:
81
AN:
292
European-Non Finnish (NFE)
AF:
0.258
AC:
17559
AN:
67988
Other (OTH)
AF:
0.346
AC:
730
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1611
3221
4832
6442
8053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.198
Hom.:
568
Bravo
AF:
0.337
Asia WGS
AF:
0.560
AC:
1945
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
4.9
DANN
Benign
0.73
PhyloP100
-0.52
PromoterAI
0.018
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3809472; hg19: chr15-45694318; API